基于双视角调查研究的糖尿病肾病精准慢性病管理
Precise Chronic Disease Management of Diabetic Nephropathy Based on Dual-Perspective Investigation and Research
DOI: 10.12677/acm.2026.161350, PDF,   
作者: 杨艳丽:北华大学临床医学院,吉林 吉林;孙昕昳*:北华大学附属医院全科医学科,吉林 吉林
关键词: 糖尿病肾病医患双视角慢性病管理问卷调查Diabetic Nephropathy Dual Perspectives of Doctors and Patients Chronic Disease Management Questionnaire Survey
摘要: 目的:本研究采用双视角调查研究方法,从患者和医生两个角度全面了解糖尿病肾病管理的现状。基于对调研数据的系统剖析,旨在为优化糖尿病肾病患者的临床结局与生存质量构建理论依据,并提供可行的临床实践指导。方法:本研究于2024年5月至2025年5月期间,选取吉林市两家社区卫生服务中心作为调研现场,分别对97名全科医生及326名糖尿病患者进行了问卷调查,所使用的问卷为课题组自行设计。采用混合研究方法,结合定量问卷调查和定性健康教育及专业知识培训,对糖尿病患者和社区医生的认知及需求进行分析。结果:326例糖尿病患者中,仅24.85%患者知晓尿微量白蛋白是诊断早期DKD最敏感的指标;38.65%患者知晓糖尿病可并发DKD;调查对象对DKD晚期常见临床症状如高血压、蛋白尿、贫血、水肿的知晓率为26.38%。经健康宣教干预后,患者对于糖尿病肾病等并发症的认知水平与相关知识掌握程度均得到显著提升(p < 0.01),但与预设的目标要求相比,相关认知水平仍有待进一步提高。调查数据显示,在参与调研的97名社区全科医生中,对糖尿病肾病患者糖化血红蛋白控制目标知晓的比例为64.95%。对于DKD患者血压控制目标知晓率61.86%。本研究对比分析了全科医生专业培训前后的知识储备情况,发现其对DKD等并发症及相关知识的掌握程度均有显著改善(p < 0.01)。结论:医患在疾病认知、管理目标方面存在显著差异,患者自我管理能力不足,社区全科医生在患者依从性上面临挑战。社区全科医生当前对糖尿病肾病(DKD)的认知水平与诊疗实践能力尚有进一步提升的空间。建议从全科医师、培训实施方及社区卫生管理部门三个维度发力,以此提升社区全科医生的DKD诊疗服务能力。必须加强对糖尿病患者进行DKD防治知识的健康教育,提高防治DKD的意识,以减少终末期肾功能衰竭的发生。
Abstract: Objective: This study adopts a dual-perspective investigation and research method to comprehensively understand the current situation of diabetic nephropathy management from the perspectives of both patients and doctors. Based on a systematic analysis of the research data, the aim is to establish a theoretical basis for optimizing the clinical outcomes and quality of life of patients with diabetic nephropathy, and to provide feasible clinical practice guidance. Methods: From May 2024 to May 2025, this study selected two community health service centers in Jilin City as the research sites. Questionnaires were conducted among 97 general practitioners and 326 diabetic patients respectively. The questionnaires used were designed by the research team themselves. A mixed research method was adopted, combining quantitative questionnaire surveys with qualitative health education and professional knowledge training, to analyze the cognition and needs of diabetic patients and community doctors. Results: Among 326 diabetic patients, only 24.85% were aware that urinary microalbumin was the most sensitive indicator for diagnosing early DKD. 38.65% of the patients were aware that diabetes could be complicated by DKD. The awareness rate of the survey subjects regarding common clinical symptoms in the advanced stage of DKD, such as hypertension, proteinuria, anemia and edema, was 26.38%. After health education intervention, the patients' cognitive level of complications such as diabetic nephropathy and their mastery of related knowledge were significantly improved (p < 0.01), but compared with the preset target requirements, the relevant cognitive level still needs to be further improved. Conclusions: Survey data shows that among the 97 community general practitioners who participated in the research, the proportion of those who were aware of the control targets for glycated hemoglobin in patients with diabetic nephropathy was 64.95%. The awareness rate of blood pressure control targets for DKD patients was 61.86%. This study comparatively analyzed the knowledge reserves of general practitioners before and after professional training and found that their mastery of complications such as DKD and related knowledge had significantly improved (p < 0.01). Conclusion: There are significant differences between doctors and patients in terms of disease cognition and management goals. Patients have insufficient self-management ability, and community general practitioners face challenges in patient compliance. There is still room for further improvement in the current understanding level and practical ability of diagnosis and treatment of diabetic nephropathy (DKD) among community general practitioners. It is suggested that efforts be made from three dimensions: general practitioners, training implementations and community health management departments, so as to enhance the DKD diagnosis and treatment service capabilities of community general practitioners. It is necessary to enhance health education on the prevention and treatment of DKD for diabetic patients, raise their awareness of DKD prevention and treatment, and thereby reduce the occurrence of end-stage renal failure.
文章引用:杨艳丽, 孙昕昳. 基于双视角调查研究的糖尿病肾病精准慢性病管理[J]. 临床医学进展, 2026, 16(1): 2880-2889. https://doi.org/10.12677/acm.2026.161350

参考文献

[1] American Diabetes Association (2014) 2. Classification and Diagnosis of Diabetes. Diabetes Care, 38, S8-S16. [Google Scholar] [CrossRef] [PubMed]
[2] Wojciechowska, J., Krajewski, W., Bolanowski, M., Kręcicki, T. and Zatoński, T. (2016) Diabetes and Cancer: A Review of Current Knowledge. Experimental and Clinical Endocrinology & Diabetes, 124, 263-275. [Google Scholar] [CrossRef] [PubMed]
[3] Valencia, W.M. and Florez, H. (2017) How to Prevent the Microvascular Complications of Type 2 Diabetes Beyond Glucose Control. BMJ, 356, i6505. [Google Scholar] [CrossRef] [PubMed]
[4] 中华医学会糖尿病学分会微血管并发症学组, 薛耀明, 朱大龙, 等. 中国糖尿病肾脏病防治指南(2021年版) [J]. 中华糖尿病杂志, 2021, 13(8): 762-784.
[5] KDOQI (2007) KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. American Journal of Kidney Diseases, 49, S12-S154.
[6] Alicic, R.Z., Rooney, M.T. and Tuttle, K.R. (2017) Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clinical Journal of the American Society of Nephrology, 12, 2032-2045. [Google Scholar] [CrossRef] [PubMed]
[7] Cameron, J.S. (2006) The Discovery of Diabetic Nephropathy: From Small Print to Centre Stage. Journal of Nephrology, 19, S75-S87.
[8] Onyenwenyi, C. and Ricardo, A.C. (2015) Impact of Lifestyle Modification on Diabetic Kidney Disease. Current Diabetes Reports, 15, Article No. 60. [Google Scholar] [CrossRef] [PubMed]
[9] Ghaderian, S.B., Hayati, F., Shayanpour, S. and Beladi Mousavi, S.S. (2015) Diabetes and End-Stage Renal Disease; A Review Article on New Concepts. Journal of Renal Injury Prevention, 4, 28-33.
[10] Tziomalos, K. and Athyros, V.G. (2015) Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis. The Review of Diabetic Studies, 12, 110-118. [Google Scholar] [CrossRef] [PubMed]
[11] Yaribeygi, H., Mohammadi, M.T., Rezaee, R. and Sahebkar, A. (2018) Fenofibrate Improves Renal Function by Amelioration of NOX‐4, IL‐18, and P53 Expression in an Experimental Model of Diabetic Nephropathy. Journal of Cellular Biochemistry, 119, 7458-7469. [Google Scholar] [CrossRef] [PubMed]
[12] Li, Z., Feng, J., Zhong, J., Lu, M., Gao, X. and Zhang, Y. (2022) Screening of the Key Genes and Signalling Pathways for Diabetic Nephropathy Using Bioinformatics Analysis. Frontiers in Endocrinology, 13, Article 864407. [Google Scholar] [CrossRef] [PubMed]
[13] 赵进, 邱川红, 蔡伟. 健康管理对早期糖尿病肾病的影响[J]. 中华健康管理学杂志, 2012, 6(2): 92-95.
[14] 魏茂碧, 吴小燕. 糖尿病肾病的早期诊断相关指标研究进展[J]. 武汉大学学报(医学版), 2023, 44(3): 380-386.
[15] Geng, T., Zhu, K., Lu, Q., Wan, Z., Chen, X., Liu, L., et al. (2023) Healthy Lifestyle Behaviors, Mediating Biomarkers, and Risk of Microvascular Complications among Individuals with Type 2 Diabetes: A Cohort Study. PLOS Medicine, 20, e1004135. [Google Scholar] [CrossRef] [PubMed]
[16] Bao, L. (2021) Intervention Value of Path-Type Health Education on Cognition and Renal Function of Patients with Diabetic Nephropathy. Computational and Mathematical Methods in Medicine, 2021, Article ID: 3665460.
[17] Calle, P. and Hotter, G. (2020) Macrophage Phenotype and Fibrosis in Diabetic Nephropathy. International Journal of Molecular Sciences, 21, Article 2806. [Google Scholar] [CrossRef] [PubMed]
[18] Corno, D. and Burns, R.J. (2022) Loneliness and Functional Limitations among Older Adults with Diabetes: Comparing Directional Models. Journal of Psychosomatic Research, 154, Article ID: 110740. [Google Scholar] [CrossRef] [PubMed]
[19] GBD 2017 Diet Collaborators (2019) Health Effects of Dietary Risks in 195 Countries, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet, 393, 1958-1972.
[20] Ko, G., Rhee, C.M., Kalantar-Zadeh, K. and Joshi, S. (2020) The Effects of High-Protein Diets on Kidney Health and Longevity. Journal of the American Society of Nephrology, 31, 1667-1679. [Google Scholar] [CrossRef] [PubMed]
[21] Rossing, P., Caramori, M.L., Chan, J.C.N., Heerspink, H.J.L., Hurst, C., Khunti, K., et al. (2022) KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney International, 102, S1-S127. [Google Scholar] [CrossRef] [PubMed]
[22] Jhee, J.H., Joo, Y.S., Kee, Y.K., Jung, S., Park, S., Yoon, C., et al. (2019) Secondhand Smoke and CKD. Clinical Journal of the American Society of Nephrology, 14, 515-522. [Google Scholar] [CrossRef] [PubMed]